Clinical and Experimental Pediatrics

Search

Search

Close


Warning: fopen(/home/virtual/pediatrics/journal/upload/ip_log/ip_log_2024-11.txt) [function.fopen]: failed to open stream: Permission denied in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 93

Warning: fwrite(): supplied argument is not a valid stream resource in /home/virtual/pediatrics/journal/ip_info/view_data.php on line 94

All issues > Volume 36(3); 1993

Original Article
J Korean Pediatr Soc. 1993;36(3):386-393. Published online March 15, 1993.
Inteleukin-6 Level in Systemic Lupus Erythematosus
Young Nae YN Yim1, Dong Soo DS Kim2
1Department of Pediatrics, Kanghwa Community Hospital, Kanghwal, Korea
2Department of Pediatrics, Yonsei University, College of Medicine, Seoul, Korea
Abstract
Systemic lupus erythematousus(SLE) is a disease affecting blood vessels and connective tissue, which are damaged by deposition of pathogenic autoantibodies and immune complexes.Although a complex disease, SLE provides a number of insights into autoimmune pathogenesis. Autoimmune disease, in general, is characterized by B cell hyperactivity which results in hypergammaglobulinemia and production of a variety of autoantibodies reactive to organ-nonspecific antigens such as DNA, RNA, and cell membrane structures. SLE patients usually show a marked increase in the number of activated and immunoglobulin-producing circulating B cells. Recently, cytokines with specific effects on immune regulating have been detected and extensively studied. One of them, Interleukin-6(IL-6), is an activated monocyte derived factor which stimulates B cell growth and differentiation. We investigated the serum IL-6 levels of SLE patients in an attempt to demonstrate their relationship with the patient's clinical manifestation, and the serum levels of C-reactive protein(CRP), circulating immune complexes(CIC2), and soluble interleukin-2 receptor(sIL-2R). The study subjects consisted of 22 patients with SLE who had visited SeveranceHOspital from July 1986 to September 1987 and 10 normal controls. The patient's sera were stored at -70℃ and later analyzed. The serum levels of IL-6 were measured by ELISA method with Inter Test-6X Human IL-6 ELISA kit ; the serum CRP levels by flurorescence polarization immunoassay ; the serum CIC levels by solid phase Clq binding assasy ; and the serum sIL-2R levels by ELISA metod. The results were as follows : The mean serum IL-6 level of SLE patient(1,366pg/ml) was higher than that of the controls (98 pg/ml)(P<0.05). Among the SLE patients studies, the mean serum IL-6 level was higher in those with vasculitis than those without. In the SLE patients studied, a linear correlation was present between the measured serum IL-6 and level and platelet count. The mean sIL-2R level of the SLE patients studied, no correlation was present between the serum IL-6 and sIL-2R levels measured. The high serum IL-6 level might play an important role int the pathogenesis of SLE.

Keywords :Systemic lupus erythematosus, Autoimmune disease, Interleukin-6

Go to Top